verezdoВестник репродуктивного здоровьяBulletin of Reproductive Health2075-65692310-421XEndocrinology Research Centre (Moscow)10.14341/brh12718verezdo-12718Research ArticleНОВОСТИNEWSНовости репродуктивной медицины. Дайджест публикаций за 2023 г., выпуск 2Reproductive medicine news. Digest of publications for 2023, issue 2https://orcid.org/0009-0008-8067-5740БарминаИ. И.BarminaI. I.

Бармина Ирина Игоревна, к.м.н.

117036, Москва, ул. Дм. Ульянова, д. 11

Irina I. Barmina, PhD in Medical sciences

 11 Dm.Ulyanova street, 117036 Moscow

barm-i@mail.ruНациональный медицинский исследовательский центр эндокринологииРоссияThe National Medical Research Center for EndocrinologyRussian Federation2024250320243148Copyright © Бармина И.И., 20242024Бармина И.И.Barmina I.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.vrz-endojournals.ru/jour/article/view/12718

В данном выпуске дайджеста новостей репродуктивной медицины автором представлена вторая часть наиболее актуальных данных метаанализов, систематических обзоров, проспективных исследований, а также инновационных методик в лечении заболеваний репродуктивной системы человека, изложенные в ведущих международных периодических изданиях в 2023 г. Основными затрагиваемыми тематиками настоящего дайджеста являются: влияние активно растущей интрамуральной миомы на исходы экстракорпорального оплодотворения; частота живорождений после лечения по поводу рака или трансплантации гемопоэтических стволовых клеток; хромосомные, гестационные и неонатальные исходы переноса мозаичных эмбрионов с генетически верифицированной анеуплоидией; применение искусственного интеллекта при отборе сперматозоидов в рамках программ вспомогательных репродуктивных технологий; персонализированная терапия пробиотиками у женщин с целью восстановления физиологичной микробиомы влагалища.

This issue of reproductive medicine news presents the second part of most relevant meta-analyses, reviews, prospective researches data, as well as innovative methods in the treatment of diseases of the reproductive system, presented in leading international periodicals in 2023. The briefly formulated list of topics contains such actual problems as: influence of active growing intramural myoma on IVF outcomes; birth rate after treatment of cancer and haemopoietic stem cell transplantation; chromosomal, gestational and neonatal outcomes of mosaic embryos with verified aneuploidy; artificial intelligence using in process of sperm selection for assisted reproductive technologies and personalized probiotic therapy of vaginal dysbiosis.

репродуктивная медицинабесплодиемиома маткиискусственный интеллектмикробиота влагалищамозаицизмreproductive medicineinfertilityuterine fibroidsartificial intelligencevaginal microbiotamosaicismReferencesErden M, Uyanik E, Polat M, et al. The effect of ≤6 cm sized noncavitydistorting intramural fibroids on in vitro fertilization outcomes: a systematic review and meta-analysis. Fertil Steril. 2023;119(6):996-1007. doi: https://doi.org/10.1016/j.fertnstert.2023.02.018Erden M., Uyanik E, Polat M., Yarali Ozbek I, Yarali H., Mumusoglu S. The effect of ≤6 cm sized noncavity-distorting intramural fibroids on in vitro fertilization outcomes: a systematic review and meta-analysis. Fertil Steril. 2023 Jun;119(6):996-1007.doi: 10.1016/ j.fertnstert.2023.02.018.Клинические рекомендации «Женское бесплодие» (утв. Министерством Здравоохранения РФ, 2021г.)Nieman CL, Kazer R, Brannigan RE, Zoloth LS, Chase-Lansdale PL, Kinahan K, et al.. Cancer survivors and infertility: a review of a new problem and novel answers. J Support Oncol (2006) 4:171–8.Nieman CL, Kazer R, Brannigan RE, et al. Cancer survivors and infertility: a review of a new problem and novel answers. J Support Oncol. 2006;4:171–8Howell S, Shalet S. Gonadal damage from chemotherapy and radiotherapy. Endocrinol Metab Clin North Am (1998) 27:927–43.Howell S, Shalet S. Gonadal damage from chemotherapy and radiotherapy. Endocrinol Metab Clin North Am. 1998;27:927–43Nielsen SN, Andersen AN, Schmidt KT, Rechnitzer C, Schmiegelow K, Bentzen JG, et al.. A 10-year follow up of reproductive function in women treated for childhood cancer. Reprod BioMed Online (2013) 27:192–200.Nielsen SN, Andersen AN, Schmidt KT, et al. A 10-year follow up of reproductive function in women treated for childhood cancer. Reprod BioMed Online. 2013;27:192–200Gracia CR, Sammel MD, Freeman E, Prewitt M, Carlson C, Ray A, et al.. Impact of cancer therapies on ovarian reserve. Fertil Steril (2012) 97:134–40.e131.Gracia CR, Sammel MD, Freeman E, et al. Impact of cancer therapies on ovarian reserve. Fertil Steril. 2012;97(1):134-140.e1. doi: https://doi.org/10.1016/j.fertnstert.2011.10.040Fraison E, Huberlant S., Labrune E, Cavalieri M., Montagut M, et al. Live birth rate after female fertility preservation for cancer or haematopoietic stem cell transplantation: a systematic review and meta-analysis of the three main techniques; embryo, oocyte and ovarian tissue cryopreservation. Hum Reprod. 2023 Mar 1;38(3):489-502. doi: 10.1093/humrep/deac249.Fraison E, Huberlant S, Labrune E, et al. Live birth rate after female fertility preservation for cancer or haematopoietic stem cell transplantation: a systematic review and meta-analysis of the three main techniques; embryo, oocyte and ovarian tissue cryopreservation. Hum Reprod. 2023;38(3):489-502. doi: https://doi.org/10.1093/humrep/deac249Viotti M., Greco E., Grifo A., Madjunkov M., Librach C. Et al. Chromosomal, gestational, and neonatal outcomes of embryos classified as a mosaic by preimplantation genetic testing for aneuploidy. Fertil Steril. 2023 Nov;120(5):957-966. doi: 10.1016/j.fertnstert.2023.07.022.Viotti M, Greco E, Grifo A, et al. Chromosomal, gestational, and neonatal outcomes of embryos classified as a mosaic by preimplantation genetic testing for aneuploidy. Fertil Steril. 2023;120(5):957-966. doi: https://doi.org/10.1016/j.fertnstert.2023.07.022Cherouveim P., Bormann C. Artificial intelligence for sperm selection-a systematic review Fertil Steril . 2023 Jul;120(1):24-31. doi: 10.1016/j.fertnstert.2023.05.157.Cherouveim P, Bormann C. Artificial intelligence for sperm selection-a systematic review. Fertil Steril. 2023;120(1):24-31. doi: https://doi.org/10.1016/j.fertnstert.2023.05.157Guahmich N. L., Borini E., Zaninovic N. Improving outcomes of assisted reproductive technologies using artificial intelligence for sperm selection. Fertil Steril. 2023 Oct;120(4):729-734. doi: 10.1016/j.fertnstert.2023.06.009.Guahmich NL, Borini E, Zaninovic N. Improving outcomes of assisted reproductive technologies using artificial intelligence for sperm selection. Fertil Steril. 2023;120(4):729-734. doi: https://doi.org/10.1016/j.fertnstert.2023.06.009Franco-Silva V., Refinetti P., Soares Jr. H., Baracat E., Pacchetti B. Vaginal microbiome and a prospective analysis of vaginal microbiome testing and personalized probiotics supplementation as a beneficial approach to unlock optimal health for women: a narrative review. Europian Gynecology and Obstetrics. 2023. Vol 5 (02): 049-054. doi.org/10.53260/EGO.235022.Franco-Silva V, Refinetti P, Soares JrH, et al. Vaginal microbiome and a prospective analysis of vaginal microbiome testing and personalized probiotics supplementation as a beneficial approach to unlock optimal health for women: a narrative review. Europian Gynecology and Obstetrics. 2023;5(02):049-054. doi: https://doi.org/10.53260/EGO.235022Franco-Silva V, Refinetti P, Soares JrH, et al. Vaginal microbiome and a prospective analysis of vaginal microbiome testing and personalized probiotics supplementation as a beneficial approach to unlock optimal health for women: a narrative review. Europian Gynecology and Obstetrics. 2023;5(02):049-054. doi: https://doi.org/10.53260/EGO.235022

The authors declare that there are no conflicts of interest present.